Weiss, Chief Executive Officer and Chairman of TG Therapeutics stated, “We are pleased to share data at this year’s ACTRIMS annual meeting, including updates from the ENABLE real world study ...

After up to three years on GA Depot, most people with PPMS have not experienced any disability progression, according to new ...

AB Science has secured a patent in Japan, valid through February 2041, covering the use of masitinib for progressive forms of MS.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented (ACTRIMS) annual forum, being held February 5 – ...

This situation goes beyond a music dispute. Artists should never have to fear that their work, platforms, or personal ...

New myasthenia gravis (MG) therapies make a more ambitious approach toward symptom control possible, following the example of MS. Research has consistently found the disease burden of myasthenia ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

Jacob Soboroff arrived at MSNBC a decade ago with limited experience in television news. Fresh off stints at YouTube and AMC, he joined the cable network as it was pivoting away from an opinionated ...

Aflibercept 8 mg administered every 12 or 16 weeks demonstrated comparable improvements in best-corrected visual acuity and central subfield retinal thickness as 2-mg dose every 8 weeks in patients ...

In August, SAIC MG launched the all-new MG4 at the Chengdu Auto Show, deeming it “the world’s first mass-produced semi-solid-state” electric vehicle. The new MG4 is available in five different trims: ...

An MS degree provides focused, technical expertise that can accelerate your career in data-driven and analytical fields. MS programs offer flexible formats—especially for working professionals—while ...